Isoproscaline
| |
| Names | |
|---|---|
| Preferred IUPAC name
2-{3,5-Dimethoxy-4-[(propan-2-yl)oxy]phenyl}ethan-1-amine | |
| Other names
2-(4-Isopropoxy-3,5-dimethoxyphenyl)ethanamine
| |
| Identifiers | |
3D model (
JSmol ) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C13H21NO3 | |
| Molar mass | 239.31 g/mol |
| Melting point | 163 to 164 °C (325 to 327 °F; 436 to 437 K) (hydrochloride) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Isoproscaline or 4-isopropoxy-3,5-dimethoxyphenethylamine is an
hallucinogenic, psychedelic, and entheogenic
effects.
Chemistry
Isoproscaline is in a class of compounds commonly known as phenethylamines, and the full chemical name is 2-(4-isopropoxy-3,5-dimethoxyphenyl)ethanamine.
Effects
Little is known about the
psychopharmacological effects of isoproscaline. In his book PiHKAL, Alexander Shulgin lists a psychedelic dosage as being 40–80 mg, with effects lasting 10–16 hours.[1]
Pharmacology
The mechanism that produces the hallucinogenic and entheogenic effects of isoproscaline is most likely to result from action as a
phenethylamines
.
Dangers
The toxicity of isoproscaline is not known.
Legality
Isoproscaline is unscheduled in the
Federal Analog Act
.
In the UK, its highly likely that this compound would be covered by the "phenylethylamine amendment" to the misuse of drugs act likely rendering it a Class A controlled drug.